SCHEDULE 13G Filed 2026-09-24 Event — SEC 0001076809-26-000101 →

GLAZER CAPITAL, LLC → BioLife Solutions, Inc. BLFS

Stake: — Shares: — Class: Common stock, par value $0.001 per share

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

26 transactions

10 buys · 11 sales · 0 awards/exercises

Issuer Cluster

10 13D/G filings on this issuer

9 other filings besides this one

Filer Track Record

11 filings by this filer

10 other filings in the data moat

Short Interest · settle 2026-09-30

DTC 4.33

3,999,252 shares short · +3.0% vs prior

Form 4 Insider Transactions · last 365d

Date	Insider	Role	Type	Shares	Price	Value
2026-10-06	Wichterman Troy	officer	Award	76,204	—	—
2026-10-06	Wichterman Troy	officer	Award	62,300	—	—
2026-10-06	Wichterman Troy	officer	F	95,933	$38.61	$3.70M
2026-10-06	Wichterman Troy	officer	Disposition	256,000	—	—
2026-10-06	GOSWAMI JOYDEEP	director	Disposition	53,156	—	—
2026-10-06	Ellingson Rachel	director	Disposition	57,995	—	—
2026-10-06	DuRoss Amy	director	Disposition	26,857	—	—
2026-10-06	Coste Catherine	director	Disposition	13,871	—	—
2026-10-06	DE GREEF RODERICK	director, officer	Award	225,670	—	—
2026-10-06	DE GREEF RODERICK	director, officer	Award	237,460	—	—
2026-10-06	DE GREEF RODERICK	director, officer	F	364,872	$38.61	$14.09M
2026-10-06	DE GREEF RODERICK	director, officer	Disposition	826,454	—	—
2026-10-06	Hunt Anthony	director	Disposition	15,046	—	—
2026-10-06	MOORE TIMOTHY L.	director	Disposition	44,943	—	—
2026-10-06	Mathew Aby J.	officer	Award	45,838	—	—
2026-10-06	Mathew Aby J.	officer	Award	40,192	—	—
2026-10-06	Mathew Aby J.	officer	F	70,000	$38.61	$2.70M
2026-10-06	Mathew Aby J.	officer	Disposition	404,608	—	—
2026-10-06	Berard Todd	officer	Award	38,198	—	—
2026-10-06	Berard Todd	officer	Award	40,192	—	—
2026-10-06	Berard Todd	officer	F	46,170	$38.61	$1.78M
2026-10-06	Berard Todd	officer	Disposition	194,786	—	—
2026-10-06	Werner Sean	officer	Award	45,838	—	—
2026-10-06	Werner Sean	officer	Award	48,232	—	—
2026-10-06	Werner Sean	officer	F	71,226	$38.61	$2.75M

Showing 25 of 26

Other 13D/G Filings on BioLife Solutions, Inc.

Filed	Form	Filer	Stake	Shares
2026-06-04	SCHEDULE 13G	Casdin Capital, LLC	—	—	view →
2026-05-22	SCHEDULE 13D/A	Casdin Capital, LLC	9.70%	4,757,165	view →
2025-08-13	SCHEDULE	Casdin Capital, LLC	15.00%	7,207,165	view →
2021-07-21	SC	VILLIGER WALTER	—	—	view →
2021-07-21	SC	GIRSCHWEILER THOMAS	—	—	view →
2020-07-24	SC	GIRSCHWEILER THOMAS	—	—	view →
2020-07-24	SC	VILLIGER WALTER	—	—	view →
2019-06-03	SC	VILLIGER WALTER	—	—	view →
2018-05-02	SC	GIRSCHWEILER THOMAS	—	—	view →

Other Filings by GLAZER CAPITAL, LLC

Filed	Form	Issuer	Stake	Shares
2026-10-09	SCHEDULE 13G	Utz Brands Inc	—	—	view →
2026-10-09	SCHEDULE 13G	Sangoma Technologies Corp	—	—	view →
2026-10-06	SCHEDULE 13G	Bowhead Specialty Holdings Inc	—	—	view →
2026-10-02	SCHEDULE 13G	Safety Insurance Group Inc	—	—	view →
2026-09-25	SCHEDULE 13G	The Baldwin Insurance Group, Inc.	—	—	view →
2026-07-01	SCHEDULE 13G	Clearwater Analytics Holdings, Inc.	—	—	view →
2026-06-25	SCHEDULE 13G	AstroNova, Inc. ALOT	—	—	view →
2026-06-10	SCHEDULE 13G	KalVista Pharmaceuticals, Inc.	—	—	view →
2026-06-08	SCHEDULE 13G	Esperion Therapeutics, Inc. ESPR	—	—	view →
2026-05-27	SCHEDULE 13G	THERMON GROUP HOLDINGS, INC.	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →